Live: Will Axon Deliver Another Blowout Quarter After the Bell?

That wraps up our initial coverage of Axon’s Q1 results. Thank you for stopping by!

Stay tuned for more updates from management’s earnings call at 5 PM EST.

While many investors worry AI could commoditize software companies, Axon’s results suggest the opposite may be happening here. AI product revenue exploded more than 700% year over year as products like Draft One, Axon Assistant, Guardian, and AI-powered workflow tools gained traction across policing and public safety ecosystems.

What makes Axon difficult to disrupt is that its software sits on top of deeply embedded hardware relationships. Body cameras, TASER systems, fleet cameras, and evidence infrastructure are already installed across agencies worldwide. Competing AI software is far less useful if you do not control the underlying hardware, evidence chain, and data ecosystem.

That dynamic may help explain why Axon continues compounding like a software platform while maintaining one of the strongest competitive positions in public safety technology.

Axon Enterprise (NASDAQ:AXON) reported strong Q1 results, with revenue rising 34% year over year to $807 million while the company raised its full-year growth outlook. Shares were modestly lower after hours despite the beat.

The bigger story was the acceleration inside Axon’s AI and software ecosystem. Software & Services revenue climbed 35% to $355 million, while AI product revenue surged more than 700% year over year. Annual recurring revenue also reached nearly $1.5 billion, up 35%, with net revenue retention holding at a strong 125%.

Management highlighted growing adoption of products like Draft One, Axon Assistant, and new AI-powered offerings unveiled at Axon Week, including Axon Vision and Axon Guardian. The company is increasingly positioning itself as an AI operating system for public safety rather than just a TASER and body camera company.

Another standout was Dedrone and drone-related products. Platform Solutions revenue jumped 95% year over year, while Dedrone revenue surged more than 300%, helped by rising interest in counter-drone systems ahead of major global events and new federal support under the Safer Skies Act.

Axon Enterprise (NASDAQ:AXON) shares are down 2% after a Q1 earnings report that beat on revenue ($807.4M vs $779.6M) and was effectively in line on adjusted EPS at $1.61 vs $1.60. Revenue growth of 34% tracks well above the FY guide of 27%-30%.

Historically, AXON beats averaged a +14.61% day-of move, while the lone miss drove a -9.43% drop. A 2% slip looks underwhelming against that backdrop, signaling the market viewed this as a thin EPS beat without the upside surprise that justifies a 262x P/E.

Investors are focused on guidance, not the headline. With YTD performance at -32.98%, the muted reaction makes sense pending tonight’s call commentary on the $6B 2028 framework.

Axon just reported earnings. Here are the key numbers:

Revenue: $807.4M vs. $779.6M expected
Adjusted EPS: $1.61 vs. $1.60 expected

Quick read:

Axon delivered another strong growth quarter, with revenue rising 34% year over year as demand for TASER devices, cloud software, and connected policing products remained strong.

Shares are initially down 2% following the report.

Axon’s Recent Insider Activity

Form 4 filings since February show 61 disposals and zero purchases, with sales clustered when shares traded near $579. CEO Patrick Smith and President Joshua Isner drove the bulk of dollar volume across early March.

The signal is muddied by 10b5-1 plans, yet the absence of any open-market buys at today’s $380.11 level, off 32.98% YTD, undercuts the conviction message.

Top 5 Analyst Questions

• Path to the $6 billion 2028 target given a 15% global tariff already baked into guidance.
• Carbyne integration cadence after its May 2026 close, plus Axon 911 monetization.
• Axon Assistant traction beyond 500 agencies and 200,000 monthly messages.
• Federal pipeline conversion and Dedrone as a new land-and-expand vector.
• Premium plan penetration past 30% of customers.

Red Flags to Watch Out For

• Adjusted gross margin slipping below 61.1%
• NRR easing from 125%
• Any softening of the 2028 framework

Tonight’s Q1 results matter less than management’s guidance for Q2 and the back half of the year. Axon Enterprise (NASDAQ:AXON) entered 2026 guiding for revenue growth of 27% to 30% and an Adjusted EBITDA margin of 25.5%, with a $6 billion revenue target for 2028.

Management’s pattern is typically to give conservative guidance then raise. FY25 was lifted every quarter before landing at $2.78B. Investors want commentary on ARR ($1.35 billion, +35% YoY), NRR at 125%, and bookings of $14.4 billion.

What could make $AXON pop: raising the FY26 range above 30%, reaffirming the 2028 target, Q2 above consensus, and a margin guide above 25.5%.

What could send shares tumbling: trimming the range, NRR slipping under 120%, tariff pressure on margins, SBC above $620 million, or any softening of the $6B target. With shares down 32.98% YTD, tone on the call drives the reaction.

Bull Case

• Momentum is real: eighth straight quarter above 30% revenue growth, with NRR at 125% and ARR over $1.35B.
• Visibility is unusually strong: $14.4B future contracted bookings, up 43% YoY.
• AI flywheel is monetizing: ~$750M in AI Era Plan bookings with 500+ agencies live on Axon Assistant.
• Analyst conviction: 18 buys vs. 2 holds.

Bear Case

• Valuation remains rich at a P/E of 263 against decelerating 2026 guidance of 27%-30%.
• Execution risk is fresh: the Q3 2025 EPS miss of 24.08% drove an 8.19% one-day drop.
• Insiders are exiting, with 61 disposals and zero purchases since February.
• GAAP quality is weak: -$50.12M operating income and free cash flow down 31.03% YoY.

This quarter will determine whether the post-Q4 sell-off reflects doubt about the 2028 path or general multiple compression.

With a forward P/E near 49x and an average analyst price target of $701.76, analysts see a lot of upside for the stock.

A clean Q1 with NRR holding above 120% would likely help meaningfully for Axon’s sentiment.